Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pythia Biosciences is a venture-backed US biotech company focused on delivering software, data, and professional services for multi-omics data analysis to accelerate drug discovery and biomedical research. Their flagship product, C-DIAM Multi-Omics Studio, enables researchers to analyze, visualize, and integrate diverse omics datasets—including single-cell, CITE-seq, Visium, Visium HD, Xenium, bulk RNA-seq, proteomics, metabolomics, and more—using interactive analytics, state-of-the-art machine learning, and standardized workflows. The company is also developing Pythiomics, a large curated single-cell multi-omics database, in collaboration with Miraomics[5][6][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pythia Biosciences.